Literature DB >> 11131342

Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime.

E Vuori-Holopainen1, H Peltola, M J Kallio.   

Abstract

UNLABELLED: Overuse of broad-spectrum antimicrobials has resulted in increasing bacterial resistance in many countries. We hypothesised that common childhood infections requiring parenteral medication are still curable with narrow-spectrum and inexpensive penicillin. A prospective and randomised study was performed in two referral hospitals in Helsinki. A total of 154 children aged 3 months to 15 years with pneumonia or other lower respiratory infections, sepsis-like infections, or other common acute infections warranting hospitalisation and parenteral antimicrobials were included. At random, 50% of children received procaine penicillin intramuscularly, the other 50% cefuroxime intravenously for 4-7 days. The course of illness was monitored with predetermined laboratory and radiological indices, by filling in a special form daily and a follow-up for 30 days after discharge. The infectious agent was searched for with a large laboratory set-up covering 23 bacterial, viral or protozoan species. The two groups were very similar at presentation. Probable aetiology was disclosed in 56% of the penicillin and in 68% of the cefuroxime recipients, the leading agent in both groups being Pneumococcus. In 8% only a viral aetiology was found. The children recovered with the same speed, regardless of which antimicrobial used, there being one possible failure in each group but no difference in the frequency of needing a physician again within 1 month of discharge. No adverse event was attributable to either drug.
CONCLUSION: Procaine penicillin is as effective and safe as cefuroxime for common community-acquired infections in immunocompetent children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131342     DOI: 10.1007/pl00008360

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.

Authors:  Eran Lavi; Oded Breuer
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

Review 2.  Short-course therapy for community-acquired pneumonia in paediatric patients.

Authors:  Shamim Qazi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.

Authors:  Mary Ann Queen; Angela L Myers; Matthew Hall; Samir S Shah; Derek J Williams; Katherine A Auger; Karen E Jerardi; Angela M Statile; Joel S Tieder
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

Review 4.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Antibiotics for community-acquired pneumonia in children.

Authors:  Rakesh Lodha; Sushil K Kabra; Ravindra M Pandey
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

6.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

7.  Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia.

Authors:  Derek J Williams; Matthew Hall; Samir S Shah; Kavita Parikh; Amy Tyler; Mark I Neuman; Adam L Hersh; Thomas V Brogan; Anne J Blaschke; Carlos G Grijalva
Journal:  Pediatrics       Date:  2013-10-28       Impact factor: 7.124

Review 8.  Management of community-acquired pneumonia in children.

Authors:  Krishne Chetty; Anne H Thomson
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

9.  Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016.

Authors:  Nicole M A Le Saux; Jennifer Bowes; Isabelle Viel-Thériault; Nisha Thampi; Julie Blackburn; Melanie Buba; Mary-Ann Harrison; Nick Barrowman
Journal:  Paediatr Child Health       Date:  2020-06-30       Impact factor: 2.253

10.  Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital.

Authors:  Anne Rowan-Legg; Nicholas Barrowman; Nazih Shenouda; Khaldoun Koujok; Nicole Le Saux
Journal:  BMC Pediatr       Date:  2012-08-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.